Table 2.
Dataset coding for all participants (n = 3667).
| Gamete storage decision |
Under 18 (n = 360) |
18-45 (n = 2722) |
Over 45 (n = 585) |
|---|---|---|---|
| Patients n (%) | Patients n (%) | Patients n (%) | |
| Gametes stored | 17 (4.7) | 147 (5.4) | 4 (0.7) |
| Patients who wanted to store gametes but were unable to | |||
| Delay in treatmenta | 46 (12.8) | 245 (9.0) | 16 (2.7) |
| Expense | 11 (3.1) | 255 (9.4) | 2 (0.3) |
| Invasive | 6 (1.7) | 12 (0.4) | 1 (0.2) |
| Locally unavailable | 2 (0.6) | 62 (2.3) | 20 (3.4) |
| Patients who did not want to store gametes | |||
| Does not want children | 131 (36.4) | 1209 (44.4) | 218 (37.3) |
| Geneticsb | 4 (1.1) | 43 (1.6) | 2 (0.3) |
| Adoption | 64 (17.8) | 414 (15.2) | 1 (0.2) |
| Family complete | 0 (0.0) | 133 (4.9) | 149 (25.5) |
| Gender dysphoria | 33 (9.2) | 139 (5.1) | 8 (1.4) |
| Infertile | 0 (0.0) | 37 (1.4) | 49 (8.4) |
| Olderc | 0 (0.0) | 0 (0.0) | 113 (19.3) |
| Outcome unknown | |||
| Wanted storage, outcome unknown | 32 (8.9) | 20 (0.7) | 0 (0.0) |
| Unknown | 14 (3.9) | 6 (0.2) | 2 (0.3) |
Note. Complete results from all patients showing all recorded gamete storage decisions across 3 age groups.
a
Treatment refers to hormone treatment – either testosterone or estrogen and progesterone. These patients wanted to store gametes but did not wish to delay starting their hormone treatment to achieve this.
b
This refers to those patients who did not wish to pass their genetics on to any future children.
c
These patients considered themselves either too old to start a family or were too old to be able to store viable gametes.